INVESTORS

CEO UPDATE

From the desk of the CEO: Vertical integration

September 23, 2023

From the Desk of the CEO

August 8, 2023
View All

Latest News

IGC Announces Results of its 2023 Annual Stockholders Meeting

August 21, 2023

IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials

August 14, 2023
View All

Presentations

Radius Research – Webinar and Deep Dive with CEO Ram Mukunda & CFO Claudia Grimaldi

February 13, 2023

IGC 8-K Presentation on its Life Sciences business

December 20, 2022
View All

SEC FILINGS

FYE 2023 10K & XBRL AS FILED – Jul 7’23

July 7, 2023

FORM TYPE 10-Q

June 30, 2023

Form 4 – Mukunda 06-27-23

June 30, 2023

Form 4 – Grimaldi 06-27-23

June 30, 2023

Form 4 – Prins 06-27-23

June 30, 2023

Form 4 – Grimaldi 06-28-22

June 30, 2023
View All

LOCATION

IGC Pharma, INC.

Our company has strategically built worldwide operations to create a cannabis manufacturing vertical and excellent technical expertise in cannabis R&D

GOVERNANCE

IGC Pharma, INC.

IGC has adopted the following policies and charters to help ensure that it retains its integrity and merits public trust and confidence.